<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504189</url>
  </required_header>
  <id_info>
    <org_study_id>CLP1000</org_study_id>
    <nct_id>NCT03504189</nct_id>
  </id_info>
  <brief_title>Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects</brief_title>
  <official_title>Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuvo-Group, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nuvo-Group, Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study will evaluate the safety of PregSense™ and Comparative Performance of
      PregSense™ versus CTG in Prenatal Monitoring of Pregnant subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PregSense™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart
      rate, maternal hear rate and uterine contractions. This study will be performed to collect
      and digitally record data from PregSense™ and the standard of care (CTG) in order to provide
      evidence of safety and agreement between PregSense™ and the gold standard NST device.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open Label</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal Heart Rate</measure>
    <time_frame>30 Minutes</time_frame>
    <description>Compare fetal heart rate data from PregSense™ versus CTG.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal Heart Rate</measure>
    <time_frame>30 MInutes</time_frame>
    <description>Compare maternal heart rate data from PregSense™ versus CTG.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uterine Contractions</measure>
    <time_frame>30 Minutes</time_frame>
    <description>Compare uterine contractions from Pregsense™ versus CTG.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety Measures</measure>
    <time_frame>Through study completion, an average of 1 hour</time_frame>
    <description>Evaluate device related adverse events</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>PregSense™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PregSense™ wearable device and the standard of care CTG (cardiotocography) will be applied for maternal-fetal monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PregSense™</intervention_name>
    <description>PregSense™ wearable device will be applied for maternal-fetal monitoring</description>
    <arm_group_label>PregSense™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiotocopraphy (CTG)</intervention_name>
    <description>Cardiotocopraphy (CTG) will be applied for maternal-fetal monitoring</description>
    <arm_group_label>PregSense™</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female age between 18-50

          -  Gestational age &gt; 32 + 0 weeks

          -  Singleton gestation

          -  Ability to understand and sign informed consent

        Exclusion Criteria:

          -  BMI (Body Mass Index) ≥ 45 and ≤15 prior pregnancy

          -  Multiple gestation

          -  Uncontrolled Hypertension

          -  Fetal Anomaly

          -  Subjects with skin problems in the abdominal area (such as flesh wounds, cuts in the
             skin, skin rashes, etc.)

          -  Subjects with implanted electronic devices (pacemaker, defibrillator, etc.)

          -  Subjects who, in the judgement of the investigator, are likely to be non-compliant or
             uncooperative during the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Iris Stein Shavel</last_name>
    <phone>+972.3.624.2266</phone>
    <email>iris.shalev@nuvo-group.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adar Shani</last_name>
    <phone>+972.3.624.2266</phone>
    <email>adar.shani@nuvo-group.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex Acker</last_name>
      <phone>215-615-4358</phone>
      <email>Alex.Acker@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Nadav Schwartz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Virginia Medical School</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Grabe</last_name>
      <phone>757-624-2241</phone>
      <email>graberj@evms.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Warsof, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heidelberg University Womens Hospital</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marin Jacobs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah Schott, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christof Sohn, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah-Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lorinne Levitt Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michal Lipschuetz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abraham Nahum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michal Novoselsky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetal monitoring, Prenatal monitoring</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

